ctDNA-Guided PARPi Therapy in Ovarian Cancer

from Listen to Gynecologic Oncology · host Gynecologic Oncology

Editor’s Choice: Circulating tumor DNA monitoring in ovarian cancer patients receiving PARPi maintenance therapy: Can we further personalize treatment?Editorial: Towards personalizing PARP inhibitor maintenance therapy for ovarian cancerHosted by:Ursula Matulonis, MD, Associate Editor of Gynecologic OncologyFeaturing:Rebecca Arhend, University of Alabama at Birmingham, Birmingham, AL, USAChristina M. Annunziata, American Cancer Society, Atlanta, GA, USACheck out more content on the journal's homepage at https://www.gynecologiconcology-online.net

Episode metadata supplied by the publisher feed · Published Jan 1, 2026

Embed this episode

Attribution link and audio player

Ready to play

ctDNA-Guided PARPi Therapy in Ovarian Cancer

0:00 25:21

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Listen to Gynecologic Oncology?

This episode is 25 minutes long.

When was this Listen to Gynecologic Oncology episode published?

This episode was published on January 1, 2026.

Can I download this Listen to Gynecologic Oncology episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!